Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
9,490.00
-390.00 (-3.95%)
At close: Feb 6, 2026
-6.04% (1Y)
| Market Cap | 220.71B -12.3% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 229,032 |
| Average Volume | 322,215 |
| Open | 9,800.00 |
| Previous Close | 9,880.00 |
| Day's Range | 9,230.00 - 9,800.00 |
| 52-Week Range | 6,970.00 - 12,670.00 |
| Beta | 0.97 |
| RSI | 46.19 |
| Earnings Date | Nov 11, 2025 |